Summary
Updated Aug 31, 2026
Scott Juda is Director of Inmune Bio, Inc. (INMB). 4 SEC Form 4 filings on record going back to 2024, most recently on 7 July 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Scott Juda has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Scott Juda go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Most Active Insiders Right Now
Scott Juda has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- J.H. Whitney Equity Partners VII, LLC - $232.77M of AVAH open-market activity in the last 90 days
- Control Empresarial de Capitales S.A. de C.V. - $230.75M of PBF open-market activity in the last 90 days
- Ernesto Bertarelli - $219.00M of MAIR open-market activity in the last 90 days
- BBRC INTERNATIONAL PTE LTD - $212.35M of VSXY open-market activity in the last 90 days
- Peter A. Feld - $192.29M of QRVO open-market activity in the last 90 days
- Nathan Blecharczyk - $190.48M of ABNB open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Scott Juda?
Scott Juda is a corporate insider, tracked as Director of Inmune Bio, Inc. (INMB). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Scott Juda submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Scott Juda's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Scott Juda and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial